From ProImmune Ltd. Apr 15 2026 ProImmune, Ltd., a global leader in immunological reagents and services, today announced a collaboration with The University of Texas Medical Branch (UTMB) Galveston National Laboratory (GNL), a high-containment, infectious disease research facility, to develop innovative tools for studying high-consequence emerging and endemic infectious diseases. Under the agreement, ProImmune's Ankyrons will be evaluated as molecular tools to enable precise detection,